Institution · Emory Healthcare
Most cited papers from Emory Healthcare
What are the most cited papers from Emory Healthcare?
The most cited paper from Emory Healthcare is "Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer" (Jean‐Charles Soria et al., 2017), with 5,475 citations. Next come "The Somatic Genomic Landscape of Glioblastoma" (5,261) and "Nanoparticle therapeutics: an emerging treatment modality for cancer" (4,238).
Showing 50 of 60 papers. Every paper with more than 720 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer Jean‐Charles Soria et al. · New England Journal of Medicine | 18 Nov 2017 | 5,475 |
| 2 | The Somatic Genomic Landscape of Glioblastoma Cameron Brennan et al. · Cell | Oct 2013 | 5,261 |
| 3 | Nanoparticle therapeutics: an emerging treatment modality for cancer Mark E. Davis, Zhuo Chen, Dong Moon Shin · Nature Reviews Drug Discovery | Sep 2008 | 4,238 |
| 4 | The role of inflammation in depression: from evolutionary imperative to modern treatment target Andrew H. Miller, Charles L. Raison · Nature reviews. Immunology | 29 Dec 2015 | 3,963 |
| 5 | The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature | 5 Feb 2020 | 3,854 |
| 6 | Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer Tony S.K. Mok, Yi-Long Lung Cancer Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine | 6 Dec 2016 | 3,396 |
| 7 | Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature | 5 Feb 2020 | 3,360 |
| 8 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics | 28 Feb 2019 | 3,277 |
| 9 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics | Apr 2022 | 2,608 |
| 10 | Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection E. John Wherry, Sang‐Jun Ha, Susan M. Kaech et al. · Immunity | Oct 2007 | 2,189 |
| 11 | Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society Andrew M. D. Wolf, Elizabeth T. H. Fontham, Timothy R. Church et al. · CA A Cancer Journal for Clinicians | 30 May 2018 | 2,040 |
| 12 | Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 Chanu Rhee, Raymund Dantes, Lauren H. Epstein et al. · JAMA | 13 Sep 2017 | 1,941 |
| 13 | Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Puja K. Mehta, Kathy K. Griendling · American Journal of Physiology-Cell Physiology | 27 Jul 2006 | 1,929 |
| 14 | Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells Susan M. Kaech, Joyce T. Tan, E. John Wherry et al. · Nature Immunology | 16 Nov 2003 | 1,861 |
| 15 | Immunological Memory and Protective Immunity: Understanding Their Relation Rafi Ahmed, David C. Gray · Science | 5 Apr 1996 | 1,789 |
| 16 | Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer Marshall R. Posner et al. · New England Journal of Medicine | 24 Oct 2007 | 1,713 |
| 17 | Breast Cancer Screening for Women at Average Risk Kevin Charles Oeffinger, Elizabeth T. H. Fontham, Ruth Etzioni et al. · JAMA | 20 Oct 2015 | 1,670 |
| 18 | mTOR regulates memory CD8 T-cell differentiation Koichi Araki, Alexandra P. Turner, Virginia Oliva Shaffer et al. · Nature | 21 Jun 2009 | 1,593 |
| 19 | Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits the Million Veteran Program et al. · Nature Genetics | 17 Sep 2018 | 1,523 |
| 20 | Initial genome sequencing and analysis of multiple myeloma Michael A. Chapman et al. · Nature | Mar 2011 | 1,472 |
| 21 | Socioeconomic Status and Cardiovascular Outcomes William M. Schultz, Heval Mohamed Kelli, John Cyril Lisko et al. · Circulation | 14 May 2018 | 1,435 |
| 22 | Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma Erwin G. Van Meir, Costas G. Hadjipanayis, A. D. Norden et al. · CA A Cancer Journal for Clinicians | May 2010 | 1,408 |
| 23 | Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Rashmi Krishna Murthy et al. · New England Journal of Medicine | 11 Dec 2019 | 1,345 |
| 24 | The Quality of Accruals and Earnings: The Role of Accrual Estimation Errors Ilia D. Dichev, Patricia Dechow · SSRN Electronic Journal | 2001 | 1,316 |
| 25 | Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis Matthew Brentnall, Luis Rodriguez-Menocal, Rebeka Ladron De Guevara et al. · BMC Cell Biology | 8 Jul 2013 | 1,298 |
| 26 | Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib Thomas C. C. Yau et al. · JAMA Oncology | Oct 2020 | 1,243 |
| 27 | Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis James N. Weinstein, Tor Devin Tosteson, Jon D. Lurie et al. · New England Journal of Medicine | 20 Feb 2008 | 1,240 |
| 28 | The neurobiology of attachment Thomas R. Insel, Larry J. Young · Nature reviews. Neuroscience | Feb 2001 | 1,172 |
| 29 | The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature | 5 Feb 2020 | 1,149 |
| 30 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. Sanjay Rajagopalan, Xiao Ping Meng, Santhini Ramasamy et al. · Journal of Clinical Investigation | Dec 1996 | 1,145 |
| 31 | A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study Charles H. Chesnut, Stuart L. Silverman, Kim Andriano et al. · The American Journal of Medicine | Sep 2000 | 1,129 |
| 32 | Reflex sympathetic dystrophy: changing concepts and taxonomy Michael D. Stanton-Hicks, Wilfrid Jänig, Samuel J. Hassenbusch et al. · Pain | Oct 1995 | 1,104 |
| 33 | The appraisal of body-cathexis: body-cathexis and the self. Paul F. Secord, Sidney M. Jourard · Journal of Consulting Psychology | 1953 | 1,058 |
| 34 | Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 S. Vincent Rajkumar et al. · Blood | 4 Feb 2011 | 1,047 |
| 35 | Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature | 5 Feb 2020 | 1,005 |
| 36 | Predicting Network Activity from High Throughput Metabolomics Shuzhao Li, Youngja H. Park, Sai Duraisingham et al. · PLoS Computational Biology | 4 Jul 2013 | 998 |
| 37 | Molecular and Functional Profiling of Memory CD8 T Cell Differentiation Susan M. Kaech, Scott E. Hemby, Ellen Neumeister Kersh et al. · Cell | Dec 2002 | 995 |
| 38 | Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis Nelson B. Watts, Steven T. Harris, Harry K. Genant et al. · New England Journal of Medicine | 12 Jul 1990 | 957 |
| 39 | Subgroup-specific structural variation across 1,000 medulloblastoma genomes Paul A. Northcott et al. · Nature | 24 Jul 2012 | 936 |
| 40 | Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients Alice Oliffson Kamphorst, Rathi Narayana Pillai, Shu Yang et al. · Proceedings of the National Academy of Sciences | 26 Apr 2017 | 906 |
| 41 | What’s Different about Social Media Networks? A Framework and Research Agenda1 Gerald C. Kane, Maryam Alavi, Giuseppe Labianca et al. · MIS Quarterly | Mar 2014 | 905 |
| 42 | An intra-tumoral niche maintains and differentiates stem-like CD8 T cells Caroline Stewart Jansen et al. · Nature | 11 Dec 2019 | 873 |
| 43 | An Interpretable Machine Learning Model for Accurate Prediction of Sepsis in the ICU Shamim Nemati, Andre L. Holder, Fereshteh Razmi et al. · Critical Care Medicine | 29 Dec 2017 | 871 |
| 44 | Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma Paul Gerard Guy Richardson et al. · Blood | 12 Apr 2010 | 869 |
| 45 | mtDNA mutations increase tumorigenicity in prostate cancer John A. Petros, Amanda K. Baumann, Eduardo Ruiz‐Pesini et al. · Proceedings of the National Academy of Sciences | 12 Jan 2005 | 839 |
| 46 | Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030 Andrew Schwartz, Kevin Xavier Farley, George N. Guild et al. · The Journal of Arthroplasty | 19 Feb 2020 | 836 |
| 47 | Promoting effective transitions of care at hospital discharge: A review of key issues for hospitalists Sunil B. Kripalani, Amy T. Jackson, Jeffrey L. Schnipper et al. · Journal of Hospital Medicine | Sep 2007 | 835 |
| 48 | Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study Sagar Lonial et al. · The Lancet Oncology | 16 Dec 2019 | 814 |
| 49 | Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition Shi-Yong Sun, Laura M. Rosenberg, Xuerong Wang et al. · Cancer Research | 15 Aug 2005 | 812 |
| 50 | Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells Robert Shigeo Ohgami, Dean R. Campagna, Eric Lieberman Greer et al. · Nature Genetics | 16 Oct 2005 | 801 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.